{"count": 1474, "results": [{"_id": "36015255", "pmid": 36015255, "pmcid": "PMC9412892", "title": "Tailoring of Rosuvastatin Calcium and Atenolol Bilayer Tablets for the Management of Hyperlipidemia Associated with Hypertension: A Preclinical Study", "journal": "Pharmaceutics", "authors": ["Elsayed MMA", "Aboelez MO", "Mohamed MS", "Mahmoud RA", "El-Shenawy AA", "Mahmoud EA", "Al-Karmalawy AA", "Santali EY", "Alshehri S", "Elsadek MEM", "El Hamd MA", "Ramadan AEH"], "date": "2022-08-04T00:00:00Z", "doi": "10.3390/pharmaceutics14081629", "meta_date_publication": "2022 Aug 4", "meta_volume": "14", "meta_issue": "8", "meta_pages": "", "score": 50280.31, "text_hl": "Tailoring of @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@Rosuvastatin Calcium@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ Bilayer Tablets for the Management of @DISEASE_Hyperlipidemias @DISEASE_MESH:D006949 @@@Hyperlipidemia@@@ Associated with @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@Hypertension@@@: A Preclinical Study", "citations": {"NLM": "Elsayed MMA, Aboelez MO, Mohamed MS, Mahmoud RA, El-Shenawy AA, Mahmoud EA, Al-Karmalawy AA, Santali EY, Alshehri S, Elsadek MEM, El Hamd MA, Ramadan AEH. Tailoring of Rosuvastatin Calcium and Atenolol Bilayer Tablets for the Management of Hyperlipidemia Associated with Hypertension: A Preclinical Study Pharmaceutics. 2022 Aug 4;14(8):. PMID: 36015255", "BibTeX": "@article{36015255, title={Tailoring of Rosuvastatin Calcium and Atenolol Bilayer Tablets for the Management of Hyperlipidemia Associated with Hypertension: A Preclinical Study}, author={Elsayed MMA and Aboelez MO and Mohamed MS and Mahmoud RA and El-Shenawy AA and Mahmoud EA and Al-Karmalawy AA and Santali EY and Alshehri S and Elsadek MEM and El Hamd MA and Ramadan AEH}, journal={Pharmaceutics}, volume={14}, number={8}}"}}, {"_id": "32801703", "pmid": 32801703, "pmcid": "PMC7414933", "title": "Poly(Acrylic Acid)-Modified MoS2 Nanoparticle-Based Transdermal Delivery of Atenolol", "journal": "Int J Nanomedicine", "authors": ["Zhang K", "Zhuang Y", "Li J", "Liu X", "He S"], "date": "2020-08-04T00:00:00Z", "doi": "10.2147/IJN.S257906", "meta_date_publication": "2020", "meta_volume": "15", "meta_issue": "", "meta_pages": "5517-5526", "score": 50272.797, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ (@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@ATE@@@) is a @GENE_ADRB1 @GENE_153 @@@beta1-adrenergic receptor@@@-blocking agent used to treat @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular diseases@@@ and @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@hypertension@@@. ", "citations": {"NLM": "Zhang K, Zhuang Y, Li J, Liu X, He S. Poly(Acrylic Acid)-Modified MoS2 Nanoparticle-Based Transdermal Delivery of Atenolol Int J Nanomedicine. 2020;15():5517-5526. PMID: 32801703", "BibTeX": "@article{32801703, title={Poly(Acrylic Acid)-Modified MoS2 Nanoparticle-Based Transdermal Delivery of Atenolol}, author={Zhang K and Zhuang Y and Li J and Liu X and He S}, journal={Int J Nanomedicine}, volume={15}, pages={5517-5526}}"}}, {"_id": "34684021", "pmid": 34684021, "pmcid": "PMC8537485", "title": "Development, Evaluation, and Molecular Docking of Oral Dissolving Film of Atenolol", "journal": "Pharmaceutics", "authors": ["Rani KC", "Parfati N", "Aryani NLD", "Winantari AN", "Fitriani EW", "Pradana AT", "Nawatila R", "Putranti AR", "Irine F", "Angelica F", "Yohanes C", "Avanti C"], "date": "2021-10-19T00:00:00Z", "doi": "10.3390/pharmaceutics13101727", "meta_date_publication": "2021 Oct 19", "meta_volume": "13", "meta_issue": "10", "meta_pages": "", "score": 50261.203, "text_hl": "The development of oral dissolving film (ODF) of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ is an attempt to enhance convenience and compliance for geriatric @SPECIES_9606 @@@patients@@@ suffering from @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@hypertension@@@. ", "citations": {"NLM": "Rani KC, Parfati N, Aryani NLD, Winantari AN, Fitriani EW, Pradana AT, Nawatila R, Putranti AR, Irine F, Angelica F, Yohanes C, Avanti C. Development, Evaluation, and Molecular Docking of Oral Dissolving Film of Atenolol Pharmaceutics. 2021 Oct 19;13(10):. PMID: 34684021", "BibTeX": "@article{34684021, title={Development, Evaluation, and Molecular Docking of Oral Dissolving Film of Atenolol}, author={Rani KC and Parfati N and Aryani NLD and Winantari AN and Fitriani EW and Pradana AT and Nawatila R and Putranti AR and Irine F and Angelica F and Yohanes C and Avanti C}, journal={Pharmaceutics}, volume={13}, number={10}}"}}, {"_id": "32785480", "pmid": 32785480, "title": "Atenolol increases dental mineralization in male offspring of treated hypertensive rats and normotensive rats.", "journal": "Braz Oral Res", "authors": ["Elias GP", "Araujo HC", "Sassaki KT", "Delbem ACB", "Antoniali C"], "date": "2020-01-01T00:00:00Z", "doi": "10.1590/1807-3107bor-2020.vol34.0086", "meta_date_publication": "2020", "meta_volume": "34", "meta_issue": "", "meta_pages": "e086", "score": 50261.17, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ increases dental mineralization in male offspring of treated @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_10116 @@@rats@@@ and normotensive @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Elias GP, Araujo HC, Sassaki KT, Delbem ACB, Antoniali C. Atenolol increases dental mineralization in male offspring of treated hypertensive rats and normotensive rats. Braz Oral Res. 2020;34():e086. PMID: 32785480", "BibTeX": "@article{32785480, title={Atenolol increases dental mineralization in male offspring of treated hypertensive rats and normotensive rats.}, author={Elias GP and Araujo HC and Sassaki KT and Delbem ACB and Antoniali C}, journal={Braz Oral Res}, volume={34}, pages={e086}}"}}, {"_id": "34964660", "pmid": 34964660, "title": "Effect of Blood Pressure Reduction on Intraocular Pressure and Ophthalmic Artery Blood Flow Velocity in Hypertension.", "journal": "J Ocul Pharmacol Ther", "authors": ["Behera G", "Nagaraj GA", "Thirunavukarasu SC", "Jayaraman R", "Murugesan R", "Subramanian A"], "date": "2022-03-01T00:00:00Z", "doi": "10.1089/jop.2021.0096", "meta_date_publication": "2022 Mar", "meta_volume": "38", "meta_issue": "2", "meta_pages": "148-155", "score": 50260.72, "text_hl": "Purpose: To evaluate the effect of reducing blood pressure (BP) by @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@ on (1) intraocular pressure (IOP) and (2) ophthalmic artery blood flow (OAF) velocity in new @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@hypertensives@@@. ", "citations": {"NLM": "Behera G, Nagaraj GA, Thirunavukarasu SC, Jayaraman R, Murugesan R, Subramanian A. Effect of Blood Pressure Reduction on Intraocular Pressure and Ophthalmic Artery Blood Flow Velocity in Hypertension. J Ocul Pharmacol Ther. 2022 Mar;38(2):148-155. PMID: 34964660", "BibTeX": "@article{34964660, title={Effect of Blood Pressure Reduction on Intraocular Pressure and Ophthalmic Artery Blood Flow Velocity in Hypertension.}, author={Behera G and Nagaraj GA and Thirunavukarasu SC and Jayaraman R and Murugesan R and Subramanian A}, journal={J Ocul Pharmacol Ther}, volume={38}, number={2}, pages={148-155}}"}}, {"_id": "36859481", "pmid": 36859481, "pmcid": "PMC9977931", "title": "Effect of long-term antihypertensive treatment on cerebrovascular structure and function in hypertensive rats", "journal": "Sci Rep", "authors": ["Naessens DMP", "de Vos J", "Richard E", "Wilhelmus MMM", "Jongenelen CAM", "Scholl ER", "van der Wel NN", "Heijst JA", "Teunissen CE", "Strijkers GJ", "Coolen BF", "VanBavel E", "Bakker ENTP"], "date": "2023-03-01T00:00:00Z", "doi": "10.1038/s41598-023-30515-0", "meta_date_publication": "2023 Mar 1", "meta_volume": "13", "meta_issue": "1", "meta_pages": "3481", "score": 50259.625, "text_hl": "@CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ similarly lower blood pressure in spontaneously @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@hypertensive@@@ rats", "citations": {"NLM": "Naessens DMP, de Vos J, Richard E, Wilhelmus MMM, Jongenelen CAM, Scholl ER, van der Wel NN, Heijst JA, Teunissen CE, Strijkers GJ, Coolen BF, VanBavel E, Bakker ENTP. Effect of long-term antihypertensive treatment on cerebrovascular structure and function in hypertensive rats Sci Rep. 2023 Mar 1;13(1):3481. PMID: 36859481", "BibTeX": "@article{36859481, title={Effect of long-term antihypertensive treatment on cerebrovascular structure and function in hypertensive rats}, author={Naessens DMP and de Vos J and Richard E and Wilhelmus MMM and Jongenelen CAM and Scholl ER and van der Wel NN and Heijst JA and Teunissen CE and Strijkers GJ and Coolen BF and VanBavel E and Bakker ENTP}, journal={Sci Rep}, volume={13}, number={1}, pages={3481}}"}}, {"_id": "37864972", "pmid": 37864972, "title": "Derivatization-free conventional and synchronous spectrofluorimetric estimation of atenolol and amlodipine.", "journal": "Spectrochim Acta A Mol Biomol Spectrosc", "authors": ["Abd El-Aziz H", "Zeid AM"], "date": "2023-10-14T00:00:00Z", "doi": "10.1016/j.saa.2023.123532", "meta_date_publication": "2023 Oct 14", "meta_volume": "305", "meta_issue": "", "meta_pages": "123532", "score": 50257.848, "text_hl": "One of these effective combinations is @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@/@CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@ which is usually administered to patients with @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@hypertension@@@. ", "citations": {"NLM": "Abd El-Aziz H, Zeid AM. Derivatization-free conventional and synchronous spectrofluorimetric estimation of atenolol and amlodipine. Spectrochim Acta A Mol Biomol Spectrosc. 2023 Oct 14;305():123532. PMID: 37864972", "BibTeX": "@article{37864972, title={Derivatization-free conventional and synchronous spectrofluorimetric estimation of atenolol and amlodipine.}, author={Abd El-Aziz H and Zeid AM}, journal={Spectrochim Acta A Mol Biomol Spectrosc}, volume={305}, pages={123532}}"}}, {"_id": "33224491", "pmid": 33224491, "pmcid": "PMC7666317", "title": "Safety of preoperative carvedilol in a patient with recent atenolol-induced pheochromocytoma crisis and cardiomyopathy: A case report", "journal": "Ann Med Surg (Lond)", "authors": ["Wannachalee T", "Chunharojrith P"], "date": "2020-11-06T00:00:00Z", "doi": "10.1016/j.amsu.2020.11.014", "meta_date_publication": "2020 Dec", "meta_volume": "60", "meta_issue": "", "meta_pages": "360-364", "score": 50256.87, "text_hl": "Based on the onset of @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@hypertensive@@@ crisis after a single dose of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and the huge right upper quadrant mass, a diagnosis of @DISEASE_Pheochromocytoma @DISEASE_MESH:D010673 @@@pheochromocytoma@@@ was suspected. ", "citations": {"NLM": "Wannachalee T, Chunharojrith P. Safety of preoperative carvedilol in a patient with recent atenolol-induced pheochromocytoma crisis and cardiomyopathy: A case report Ann Med Surg (Lond). 2020 Dec;60():360-364. PMID: 33224491", "BibTeX": "@article{33224491, title={Safety of preoperative carvedilol in a patient with recent atenolol-induced pheochromocytoma crisis and cardiomyopathy: A case report}, author={Wannachalee T and Chunharojrith P}, journal={Ann Med Surg (Lond)}, volume={60}, pages={360-364}}"}}, {"_id": "39505564", "pmid": 39505564, "title": "The fate of atenolol in wastewater treatment plants of representative densely urban agglomerations in China.", "journal": "J Environ Qual", "authors": ["Xu Q", "Luo L", "Zhu Z", "Liu X", "Ong TV", "Wong JWC", "Pan M"], "date": "2024-11-06T00:00:00Z", "doi": "10.1002/jeq2.20653", "meta_date_publication": "2024 Nov 6", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50254.85, "text_hl": "...@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ (@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@ATL@@@) that can decrease heart rate and reduce @GENE_REN @GENE_5972 @@@renin@@@ release is extensively used in the treatment of @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@hypertension@@@, @DISEASE_Angina_Pectoris @DISEASE_MESH:D000787 @@@angina@@@, and other diseases. ", "citations": {"NLM": "Xu Q, Luo L, Zhu Z, Liu X, Ong TV, Wong JWC, Pan M. The fate of atenolol in wastewater treatment plants of representative densely urban agglomerations in China. J Environ Qual. 2024 Nov 6;():. PMID: 39505564", "BibTeX": "@article{39505564, title={The fate of atenolol in wastewater treatment plants of representative densely urban agglomerations in China.}, author={Xu Q and Luo L and Zhu Z and Liu X and Ong TV and Wong JWC and Pan M}, journal={J Environ Qual}}"}}, {"_id": "32215501", "pmid": 32215501, "pmcid": "PMC7077577", "title": "Passive Cigarette Smoking Impact on Blood Pressure Response to Epinephrine and Felypressin in 1K1C Hypertensive Rats Treated or not with Atenolol", "journal": "Arq Bras Cardiol", "authors": ["Fleury CA", "Almeida EPM", "Dionisio TJ", "Calvo AM", "Oliveira GM", "Amaral SL", "Santos CF", "Faria FAC"], "date": "2020-02-01T00:00:00Z", "doi": "10.36660/abc.20180433", "meta_date_publication": "2020 Feb", "meta_volume": "114", "meta_issue": "2", "meta_pages": "295-303", "score": 50254.508, "text_hl": "Smoke significantly increased felypressin maximal @<m>DISEASE_Hypertension</m> @DISEASE_MESH:D006973 @@@hypertensive@@@ response only in the @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@-treated group.", "citations": {"NLM": "Fleury CA, Almeida EPM, Dionisio TJ, Calvo AM, Oliveira GM, Amaral SL, Santos CF, Faria FAC. Passive Cigarette Smoking Impact on Blood Pressure Response to Epinephrine and Felypressin in 1K1C Hypertensive Rats Treated or not with Atenolol Arq Bras Cardiol. 2020 Feb;114(2):295-303. PMID: 32215501", "BibTeX": "@article{32215501, title={Passive Cigarette Smoking Impact on Blood Pressure Response to Epinephrine and Felypressin in 1K1C Hypertensive Rats Treated or not with Atenolol}, author={Fleury CA and Almeida EPM and Dionisio TJ and Calvo AM and Oliveira GM and Amaral SL and Santos CF and Faria FAC}, journal={Arq Bras Cardiol}, volume={114}, number={2}, pages={295-303}}"}}]}